Biodegradable dextran-polylactide hydrogel networks: their swelling, morphology and the controlled release of indomethacin.

Biodegradable polymer hydrogel networks based on hydrophilic dextran derivative of allyl isocyanate (dex-AI) and hydrophobic poly (D,L) lactide diacrylate macromer (PDLLAM) were synthesized, and their swelling and morphological properties were studied. During a 2-day incubation, the higher the PDLLAM composition in the hydrogel, the slower the swelling as well as the lower the extent of swelling were. A 3D porous network structure was observed by scanning electron microscope. The rate of formation of this 3D porous network structure depended on the hydrophilicity of the components, their composition ratio, and the degradation time. The highly hydrophilic dex-AI component facilitated the formation of this 3D porous network structure at an earlier immersion period, while the degradability of the PDLLAM component would make this 3D porous network structure more open at a later immersion period. Indomethacin, a low molecular weight and moderately hydrophobic drug, was incorporated into the hydrogels for the release study in pH 7.4 phosphate buffer solution at 37 degrees C. The release kinetics suggested, as the PDLLAM composition increased, the indomethacin diffusion coefficient (D) and release half life time (t(1/2)) decreased, while the release index n increased. The controlled release mechanism was determined by the combination of three factors: the rate and degree of formation of swelling-induced 3D porous structure in the hydrogel, the hydrolytic degradation of PDLLAM components, and the hydrophobic interaction between PDLLAM and IDM.

[1]  T. Kissel,et al.  Parenteral protein delivery systems using biodegradable polyesters of ABA block structure, containing hydrophobic poly(lactide-co-glycolide) A blocks and hydrophilic poly(ethylene oxide) B blocks , 1996 .

[2]  N. Peppas,et al.  Transport of ionizable drugs and proteins in crosslinked poly(acrylic acid) and poly(acrylic acid-co-2-hydroxyethyl methacrylate) hydrogels. II. Diffusion and release studies , 1997 .

[3]  Alan Smith,et al.  Evaluation of poly(lactic acid) as a biodegradable drug delivery system for parenteral administration , 1986 .

[4]  H. Allcock,et al.  Synthesis and characterization of pH-sensitive poly(organophosphazene) hydrogels. , 1996, Biomaterials.

[5]  R. Mashelkar,et al.  Pendent chain linked delivery systems: I facile hydrolysis through anchimeric effect , 1996 .

[6]  J. Kopeček,et al.  Novel pH-sensitive hydrogels with adjustable swelling kinetics. , 1998, Biomaterials.

[7]  Yi-you Huang,et al.  Drug release from PLA/PEG microparticulates , 1997 .

[8]  K. Nakamae,et al.  A hydrophobically-modified bioadhesive polyelectrolyte hydrogel for drug delivery , 1997 .

[9]  J. Israelachvili Intermolecular and surface forces , 1985 .

[10]  H. Brøndsted,et al.  Dextran hydrogels for colon-specific drug delivery , 1995 .

[11]  D. Cohn,et al.  Poly(ether urethane) oligomers as poly(HEMA) crosslinkers , 1994 .

[12]  A S Hoffman,et al.  An AB block copolymer of oligo(methyl methacrylate) and poly(acrylic acid) for micellar delivery of hydrophobic drugs. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[13]  Nicholas A. Peppas,et al.  A simple equation for description of solute release II. Fickian and anomalous release from swellable devices , 1987 .

[14]  J. Gayet,et al.  High water content BSA-PEG hydrogel for controlled release device: Evaluation of the drug release properties , 1996 .

[15]  Y. Yokomizo,et al.  The effects of phospholipids on the percutaneous penetration of indomethacin through the dorsal skin of guinea pig in vitro. 2. The effects of the hydrophobic group in phospholipids and a comparison with general enhancers , 1996 .

[16]  W. Hennink,et al.  In vivo biocompatibility of dextran-based hydrogels. , 2000, Journal of biomedical materials research.

[17]  J. Fox,et al.  A novel skeletal drug delivery system using self-setting calcium phosphate cement VIII: the relationship between in vitro and in vivo drug release from indomethacin-containing cement , 1997 .

[18]  K. Sugibayashi,et al.  Release kinetics of indomethacin from pressure sensitive adhesive matrices , 1997 .

[19]  N. Peppas,et al.  Present and future applications of biomaterials in controlled drug delivery systems. , 1981, Biomaterials.

[20]  Kinam Park,et al.  Biodegradable Hydrogels for Drug Delivery , 1993 .

[21]  H. Brøndsted,et al.  Crosslinked dextran--a new capsule material for colon targeting of drugs. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[22]  C. Migliaresi,et al.  A study on the in vitro degradation of poly(lactic acid). , 1994, Journal of biomaterials science. Polymer edition.

[23]  Y. M. Lee,et al.  Methoxy poly(ethylene glycol)/epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterization. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[24]  C. Nastruzzi,et al.  Production and characterization of biodegradable microparticles for the controlled delivery of proteinase inhibitors , 1996 .

[25]  Y. Bae,et al.  New biodegradable polymers for injectable drug delivery systems. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[26]  Wim E. Hennink,et al.  Controlled release of proteins from dextran hydrogels , 1996 .

[27]  S. Lee,et al.  Controlled release of platelet-derived growth factor from porous poly(L-lactide) membranes for guided tissue regeneration. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[28]  Seung Jin Lee,et al.  Porous poly(l-lactide) membranes for guided tissue regeneration and controlled drug delivery: membrane fabrication and characterization , 1997 .

[29]  Chih-Chang Chu,et al.  Synthesis and characterization of biodegradable hydrophobic-hydrophilic hydrogel networks with a controlled swelling property , 2000 .

[30]  Chih-Chang Chu,et al.  Synthesis and characterization of biodegradable network hydrogels having both hydrophobic and hydrophilic components with controlled swelling behavior , 1999 .

[31]  Y. Lee,et al.  Albumin release from bioerodible hydrogels based on semi-interpenetrating polymer networks composed of poly(ϵ-caprolactone) and poly(ethylene glycol) macromer , 1997 .

[32]  C. Chu,et al.  Synthesis and characterization of dextran-maleic acid based hydrogel. , 1999, Journal of biomedical materials research.

[33]  Wim E. Hennink,et al.  Degradation and release behavior of dextran-based hydrogels , 1997 .

[34]  O. Corrigan,et al.  Investigation of the mechanisms governing the release of levamisole from poly-lactide-co-glycolide delivery systems , 1996 .

[35]  A. Coombes,et al.  The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[36]  Chong-Su Cho,et al.  METHOXY POLY(ETHYLENE GLYCOL) AND CAPROLACTONE AMPHIPHILIC BLOCK CO POLYMERIC MICELLE CONTAINING INDOMETHACIN. II: MICELLE FORMATION AND DRUG RELEASE BEHAVIORS , 1998 .